Canada Life
ARCT icon

Canada Life’s Arcturus Therapeutics ARCT Stock Holding History

Canada Life’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Buy
17,353
+4,559
+36% +$35.9K ﹤0.01% 1662
2026
Q1 		$99K Buy
12,794
+785
+7% +$5.73K ﹤0.01% 1693
2025
Q4 		$73K Buy
12,009
+4,737
+65% +$51.2K ﹤0.01% 1753
2025
Q3 		$136K Buy
7,272
+1,567
+27% +$25.2K ﹤0.01% 1729
2025
Q2 		$74K Buy
5,705
+241
+4% +$2.85K ﹤0.01% 1793
2025
Q1 		$58K Sell
5,464
-15
-0.3% -$238 ﹤0.01% 1846
2024
Q4 		$92K Sell
5,479
-571
-9% -$10.7K ﹤0.01% 1825
2024
Q3 		$140K Buy
6,050
+701
+13% +$15K ﹤0.01% 1813
2024
Q2 		$130K Buy
5,349
+857
+19% +$26K ﹤0.01% 1850
2024
Q1 		$152K Buy
4,492
+428
+11% +$15.2K ﹤0.01% 1868
2023
Q4 		$127K Sell
4,064
-341
-8% -$8.11K ﹤0.01% 1899
2023
Q3 		$112K Buy
4,405
+1,825
+71% +$56.2K ﹤0.01% 1940
2023
Q2 		$74K Sell
2,580
-99
-4% -$2.69K ﹤0.01% 1957
2023
Q1 		$64K Buy
2,679
+616
+30% +$11.1K ﹤0.01% 2030
2022
Q4 		$35K Buy
2,063
+247
+14% +$4.31K ﹤0.01% 2146
2022
Q3 		$27K Buy
1,816
+167
+10% +$2.8K ﹤0.01% 2204
2022
Q2 		$26K Buy
1,649
+186
+13% +$3.65K ﹤0.01% 2208
2022
Q1 		$41K Buy
1,463
+150
+11% +$3.83K ﹤0.01% 2200
2021
Q4 		$48K Buy
1,313
+145
+12% +$5.91K ﹤0.01% 2181
2021
Q3 		$56K Hold
1,168
– – ﹤0.01% 2200
2021
Q2 		$39K Hold
1,168
– – ﹤0.01% 2333
2021
Q1 		$48K Hold
1,168
– – ﹤0.01% 2306
2020
Q4 		$51K Hold
1,168
– – ﹤0.01% 2269
2020
Q3 		$50K Hold
1,168
– – ﹤0.01% 2178
2020
Q2 		$54K Buy
+1,168
New +$40.3K ﹤0.01% 2203

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Canada Life's ARCT Position: Q2 2026 in Review

Canada Life increased its Arcturus Therapeutics (ARCT) stake by 36% in Q2 2026, buying an estimated $35.9K and bringing the position to 17,353 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Canada Life first reported a position in ARCT in Q2 2020 and has held it in 25 quarters since. The position peaked at $152K in Q1 2024. 136 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Canada Life held 17,353 shares of Arcturus Therapeutics worth $116K as of Q2 2026.
  • Canada Life bought 4,559 Arcturus Therapeutics shares in Q2 2026, an estimated $35.9K.
  • Arcturus Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1662 holding.
  • Canada Life first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Canada Life's Arcturus Therapeutics position peaked at $152K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.